WuXi Biologics (Cayman) Inc - ESG Rating & Company Profile powered by AI
The page contains a Q&A table about WuXi Biologics (Cayman) Inc. The Disclosure score covers seventeen UN Sustainable Development Goals including: 'No Poverty', 'Climate Action' and 'Peace, Justice & Strong Institutions'. The assessment of WuXi Biologics (Cayman) Inc incorporates information from across the internet as well as from public disclosures by WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.6; made up of an environmental score of 6.0, social score of 7.0 and governance score of 6.9.
6.6
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
337 | Sonoma Pharmaceuticals Inc | 6.7 | High |
337 | Zhong Yuan Bio-Technology Holdings Ltd | 6.7 | High |
389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
389 | Austar Lifesciences Ltd | 6.6 | High |
389 | Alligator Bioscience AB | 6.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does WuXi Biologics (Cayman) Inc have an accelerator or VC vehicle to help deliver innovation?
Does WuXi Biologics (Cayman) Inc disclose current and historical energy intensity?
Does WuXi Biologics (Cayman) Inc report the average age of the workforce?
Does WuXi Biologics (Cayman) Inc reference operational or capital allocation in relation to climate change?
Does WuXi Biologics (Cayman) Inc disclose its ethnicity pay gap?
Does WuXi Biologics (Cayman) Inc disclose cybersecurity risks?
Does WuXi Biologics (Cayman) Inc offer flexible work?
Does WuXi Biologics (Cayman) Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does WuXi Biologics (Cayman) Inc disclose the number of employees in R&D functions?
Does WuXi Biologics (Cayman) Inc conduct supply chain audits?
Does WuXi Biologics (Cayman) Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does WuXi Biologics (Cayman) Inc conduct 360 degree staff reviews?
Does WuXi Biologics (Cayman) Inc disclose the individual responsible for D&I?
Does WuXi Biologics (Cayman) Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does WuXi Biologics (Cayman) Inc disclose current and / or historical scope 2 emissions?
Does WuXi Biologics (Cayman) Inc disclose water use targets?
Does WuXi Biologics (Cayman) Inc have careers partnerships with academic institutions?
Did WuXi Biologics (Cayman) Inc have a product recall in the last two years?
Does WuXi Biologics (Cayman) Inc disclose incidents of discrimination?
Does WuXi Biologics (Cayman) Inc allow for Work Councils/Collective Agreements to be formed?
Has WuXi Biologics (Cayman) Inc issued a profit warning in the past 24 months?
Does WuXi Biologics (Cayman) Inc disclose parental leave metrics?
Does WuXi Biologics (Cayman) Inc disclose climate scenario or pathway analysis?
Does WuXi Biologics (Cayman) Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does WuXi Biologics (Cayman) Inc disclose the pay ratio of women to men?
Does WuXi Biologics (Cayman) Inc support suppliers with sustainability related research and development?
Does WuXi Biologics (Cayman) Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does WuXi Biologics (Cayman) Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is WuXi Biologics (Cayman) Inc involved in embryonic stem cell research?
Does WuXi Biologics (Cayman) Inc disclose GHG and Air Emissions intensity?
Does WuXi Biologics (Cayman) Inc disclose its waste policy?
Does WuXi Biologics (Cayman) Inc report according to TCFD requirements?
Does WuXi Biologics (Cayman) Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does WuXi Biologics (Cayman) Inc disclose energy use targets?
Does WuXi Biologics (Cayman) Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does WuXi Biologics (Cayman) Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for WuXi Biologics (Cayman) Inc
These potential risks are based on the size, segment and geographies of the company.
WuXi Biologics (Cayman) Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sales of medicals; vaccine CDMO and related business; and material supplier activities. It has strategic partnerships with Almirall, S.A.; Vir Biotechnology, Inc.; Aravive, Inc.; Tubulis GmbH; Arcus Biosciences, Inc.; AC Immune SA; and AB2 Bio Ltd. The company was incorporated in 2014 and is headquartered in Wuxi, China. WuXi Biologics (Cayman) Inc. is a subsidiary of WuXi Biologics Holdings Limited.